Case Report: Successful Management of a Refractory Plasmablastic Lymphoma Patient With Tislelizumab and Lenalidomide
Lili Cheng, Weili Zhao(Shanghai Institute of Hematology), Chaofu Wang(Shanghai Jiao Tong University), Yan Wang(University of Electronic Science and Technology of China), Pengpeng Xu(Shanghai Jiao Tong University), Qi Song(Macau University of Science and Technology), Mengke Liu(Shanghai Jiao Tong University), Ying Qian(Shanghai Jiao Tong University), Shu Cheng(Shanghai Jiao Tong University), Li Wang(University of Science and Technology of China), Hongmei Yi(Shanghai Jiao Tong University)
Cited by 15
Related Papers
Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients
|EBioMedicine|2020|432
Conformationally Restricted Aza‐Bodipy: A Highly Fluorescent, Stable, Near‐Infrared‐Absorbing Dye
|Angewandte Chemie International Edition|2005|290
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|238
BODIPY‐Based Fluorescent Probes for Biothiols
|Chemistry - A European Journal|2019|227
A single-cell transcriptomic landscape of the lungs of patients with COVID-19
|Nature Cell Biology|2021|214